We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 101-120 of 1,958 results
  1. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation

    The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with...

    Amal Farahat Allam, Nancy Abd-elkader Hagras, ... Nermine Mogahed Fawzy Hussein Mogahed in Journal of Parasitic Diseases
    Article 10 August 2021
  2. Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant

    The role of WT1 protein in hematopoiesis and leukemogenesisis incompletely elucidated. WT1 overexpression is common in acute myeloid leukemia (AML);...

    Siba El Hussein, Courtney D. DiNardo, ... Sanam Loghavi in Bone Marrow Transplantation
    Article 07 January 2022
  3. Current status and future perspectives in targeted therapy of NPM1-mutated AML

    Nucleophosmin 1 (NPM1) is a nucleus-cytoplasmic shuttling protein which is predominantly located in the nucleolus and exerts multiple functions,...

    Roberta Ranieri, Giulia Pianigiani, ... Brunangelo Falini in Leukemia
    Article Open access 25 August 2022
  4. Meta-analysis of reported presacral myelolipomas, including a report of a new case

    Background

    Presacral myelolipomas form a rare disease and are often found incidentally in imaging diagnostics.

    Case presentation

    In this study, we...

    Congde Xu, Atsuko Kasajima, ... Helmut Friess in Journal of Medical Case Reports
    Article Open access 01 February 2023
  5. The discrepancy of antemortem clinical diagnosis and postmortem autopsy diagnosis of lung pathologies in under-five deaths and the reasons for discrepancies: a case series analysis

    Background

    Diagnostic autopsy is the most reliable approach to definitively ascertain the cause of death and evaluate the accuracy of antemortem...

    Haleluya Leulseged, Chris A. Rees, ... Nega Assefa in BMC Pediatrics
    Article Open access 28 May 2024
  6. GK-1 effectively reduces angiogenesis and prevents T cell exhaustion in a breast cancer murine experimental model

    Breast cancer is the leading malignancy in women worldwide, both in terms of incidence and mortality. Triple-negative breast cancer (TNBC) is the...

    Juan A. Hernández-Aceves, Jacquelynne Cervantes-Torres, ... Edda Sciutto in Cancer Immunology, Immunotherapy
    Article Open access 22 September 2023
  7. Nelarabine-containing salvage therapy and conditioning regimen in transplants for pediatric T-cell acute lymphoblastic leukemia and lymphoma

    Therapy for relapsed or refractory (r/r) T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in children is...

    Masato Yanagi, Makiko Mori, ... Katsuyoshi Koh in International Journal of Hematology
    Article 01 February 2024
  8. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy

    Transcripts longer than 200 nucleotides that are not translated into proteins are known as long non-coding RNAs, or lncRNAs. Now, they are becoming...

    Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, ... Ahmed Hussein Zwamel in Medical Oncology
    Article 07 June 2024
  9. Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials

    Purpose of Review

    The management of myelofibrosis is risk-adapted when considering transplant eligibility and symptom-directed, prioritizing the most...

    Article 09 September 2021
  10. The value of blood and urine metabolomics in differential diagnosis of cholestasis in infants

    Background

    Early detection of biliary atresia (BA) is a great challenge providing the main useful way to improve its clinical consequence. Promising...

    Samah Abdelfatah Eshiaty, Shimaa Abdelsattar, ... Hala Elsaid in Egyptian Liver Journal
    Article Open access 09 February 2023
  11. Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy

    Myeloproliferative neoplasms (MPN) show dysregulated JAK2 signaling. JAK2 inhibitors provide clinical benefits, but compensatory activation of MAPK...

    Sime Brkic, Simona Stivala, ... Sara C. Meyer in Leukemia
    Article Open access 03 September 2021
  12. Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice

    Precise regulation of chromatin architecture is vital to physiological processes including hematopoiesis. ARID1A is a core component of the mammalian...

    Lin Han, Vikas Madan, ... H. Phillip Koeffler in Leukemia
    Article Open access 11 March 2019
  13. Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature

    Background

    Primary plasmacytomas are localized proliferations of clonal plasma cells occurring in the absence of a systemic plasma cell dyscrasia such...

    Leonard Naymagon, Maher Abdul-Hay in Journal of Medical Case Reports
    Article Open access 22 May 2019
  14. Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche

    Inflammation in the bone marrow (BM) microenvironment is a constitutive component of leukemogenesis in acute myeloid leukemia (AML). Current evidence...

    Ding-Wen Chen, Jian-Meng Fan, ... Peter Kurre in Leukemia
    Article Open access 16 January 2024
  15. Stroma-derived neoplasms and pseudoneoplastic lesions of the spleen: a select review of pathologic and CT/MRI findings

    A wide spectrum of benign and malignant primary mesenchymal tumors and tumor-like lesions of the spleen has been recently included under the umbrella...

    Aditya S. Prasad, Steven S. Chua, ... Venkateswar R. Surabhi in Abdominal Radiology
    Article 27 June 2024
  16. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy

    Acute myeloid leukemia (AML) is a malignant hematological neoplastic disease. Autocrine or paracrine cytokines released by leukemic cells regulate...

    Rui Hu, **aosui Ling, ... Yunyun Du in Clinical and Experimental Medicine
    Article 04 November 2023
  17. Il-1r1 drives leukemogenesis induced by Tet2 loss

    Sarah S. Burns, Ramesh Kumar, ... Reuben Kapur in Leukemia
    Article Open access 12 August 2022
  18. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome

    Macrophage activation syndrome (MAS) is a life-threatening complication of pediatric rheumatic diseases, occurring most commonly in children with...

    Natsumi Inoue, Grant S. Schulert in Arthritis Research & Therapy
    Article Open access 25 March 2023
  19. Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25—a case report of rare entity

    Systemic mastocytosis (SM) is a rare hematological neoplasm caused by the excessive proliferation of pathological mast cells that accumulate in the...

    Eliza Zaremba-Pataj, Elżbieta Patkowska, ... Justyna Chlebowska-Tuz in Journal of Hematopathology
    Article 20 January 2023
Did you find what you were looking for? Share feedback.